AMVUTTRA

Serial Number 97057480
Registration 6897160
700

Registration Progress

Application Filed
Oct 3, 2021
Under Examination
Mar 22, 2022
Approved for Publication
Jan 25, 2022
Published for Opposition
Jan 25, 2022
Registered
Nov 8, 2022

Basic Information

Serial Number
97057480
Registration Number
6897160
Filing Date
October 3, 2021
Registration Date
November 8, 2022
Published for Opposition
January 25, 2022
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 8, 2022
Registration
Registered
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

Next Deadline
1218 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-11-08)
Due Date
November 08, 2028
Grace Period Ends
May 08, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

21 events
Date Code Type Description
Nov 8, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 8, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 1, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 30, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 1, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 1, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jul 15, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 15, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 15, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 15, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 15, 2022 EISU I TEAS STATEMENT OF USE RECEIVED
Jul 15, 2022 IUAF S USE AMENDMENT FILED
Mar 22, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 25, 2022 PUBO A PUBLISHED FOR OPPOSITION
Jan 25, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 5, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2021 DOCK D ASSIGNED TO EXAMINER
Dec 18, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 30, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 29, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 6, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of amyloidosis
First Use Anywhere: Jul 1, 2022
First Use in Commerce: Jul 5, 2022

Additional Information

Design Mark
The mark consists of the word AMVUTTRA shown in pink, and the design of a stylized double helix composed of bands shown in pink, blue and green.
Color Claim
The color(s) pink, blue and green is/are claimed as a feature of the mark.

Classification

International Classes
005